Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcome of a New Trimodality Bladder Perservation Protocol for Patients With Muscle Invasive Bladder Cancer

NCT07402317 is registered in ClinicalTrials.gov with Al-Azhar University as lead sponsor.

NCT NCT07402317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07402317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcome of a New Trimodality Bladder Perservation Protocol for Patients With Muscle Invasive Bladder Cancer
Lead sponsor
Al-Azhar University
Phase
Not applicable
Overall status
Completed
Start date
December 11, 2018
Completion date
January 25, 2023
Enrollment
97 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer treatment